Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioNTech SE (BNTX) said it projects total company revenues of approximately 3 billion euros for financial year 2024, mainly driven by the COVID-19 vaccine franchise which is expected to remain profitable given the cost sharing structure with its partner Pfizer Inc.
BioNTech, a leading biotechnology company, on Monday inaugurated its first manufacturing plant for mRNA vaccines in Africa in Rwanda capital of Kigali.....
BioNTech will develop and commission a state-of-the-art mRNA clinical-scale manufacturing facility at La Trobe University's Melbourne campus.
The Defense Department's COVID-19 vaccine mandate has been rescinded, but two ex-service members are still asking the Supreme Court to consider its constitutionality – in a case with the potentiality
COVID-19 vaccine maker BioNTech said on Tuesday the European Patent Office has declared as invalid an mRNA patent that has been invoked by Moderna in litigation about alleged an patent violation by BioNTech and its partner Pfizer. "We understand and welcome the European Patent Office’s decision to revoke Moderna’s European Patent 3 718 565 B1," the German biotech firm said in a statement. "The European Patent Office’s decision is an important one as we believe that this and others of Moderna’s patents do not meet the requirements for grant and shoul...